ClinicalTrials.govpublic full text
Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers
breast neoplasms, breast cancer, neoadjuvant therapy, chemotherapy, positron-emission tomography, pet-ct, fdg, fluorodeoxyglucose, diagnosis, prognosis, pathological complete response, molecular biology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1030297
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.